Bello v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided December 20, 2024·No. 13-0349V·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: November 25, 2024

* * * * * * * * * * * * * * CRISTAL BELLO, * No. 13-349V * Special Master Young Petitioner, * * v. * * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * *

Mark T. Sadaka, Law Offices of Sadaka Associates, LLC, Englewood, NJ, for Petitioner; Kimberly Shubert Davey, United States Department of Justice, Washington, DC, for Respondent.

DECISION AWARDING ATTORNEYS’ FEES AND COSTS1

On May 22, 2013, Cristal Bello (“Petitioner”) filed a petition for compensation pursuant to the National Vaccine Injury Compensation Program. 42 U.S.C. §§ 300aa-10 to -34 (2018)2 (the “Vaccine Act” or “Program”). Pet. at 1, ECF No. 1. Petitioner alleged that the human papillomavirus (“HPV”) vaccination Petitioner received on June 4, 2010, caused her to suffer from premature ovarian failure (“POF”/“POI”) Id. Petitioner’s case was ultimately consolidated with a group of other cases all alleging that the HPV vaccine caused POF. On August 30, 2021, I issued a Ruling on Althen prong one for this and seven other petitioners who had “consolidated their claims for the purpose of determining whether they have presented a sufficient causation theory.” Findings of Fact and Conclusions of Law (“Findings of Fact”) at 24, ECF No. 146 at 1-2; Brayboy v. Sec’y of Health & Human Servs., No. 15-183V, 2021 WL 4453146, *1 (Fed. Cl. Spec. Mstr.

1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub L. No. 99-660, 100 Stat. 3755. Aug. 30, 2021). I found that “the theory presented, while not applicable to all of them, does survive Althen prong one, [i]n instances where a petitioner can establish by a preponderant standard that she suffers from autoimmune POI.” ECF No. 146 at 24; Brayboy, 2021 WL 4453146, at *19. Following that ruling, determination of whether Ms. Bello suffered from autoimmune POI and factual analysis pursuant to Althen prongs two and three remained outstanding. On February 23, 2023, I issued my decision denying entitlement and dismissing the petition, concluding that Ms. Bello failed to show by a preponderant standard that her POI was autoimmune in nature, and thus there was no persuasive evidence that her injury was caused-in-fact by her HPV vaccination via the biological mechanism she proposed pursuant to Althen prong one. ECF No. 174.

Thereafter, Petitioner filed a Motion for Review of the entitlement decision to the U.S. Court of Federal Claims, which was assigned to Judge Stephen S. Schwartz. ECF No. 176; ECF No. 177. On August 22, 2023, Judge Schwartz denied Petitioner’s motion, sustaining the February 23, 2023, entitlement decision. Bello v. Sec’y of Health & Human Servs., 167 Fed. Cl. 517 (2023).

On February 19, 2024, Petitioner filed a final motion3 for attorneys’ fees and costs incurred by her current counsel at the Law Offices of Sadaka Associates, LLC, and by Petitioner’s prior counsel at Krueger & Hernandez S.C. Pet’r’s Mot. for Final Attorneys’ Fees and Costs [hereinafter “Pet’r’s Mot. for AFC”], ECF No. 187. Petitioner requests total attorneys’ fees and costs in the amount of $66,137.974, representing $44,026.61 in attorneys’ fees and $10,555.56 in attorneys’ costs incurred by the Law Offices of Sadaka Associates, LLC, and $11,388.80 in attorneys’ fees and $166.98 in attorneys’ costs incurred by Krueger & Hernandez S.C. Pet’r’s Mot. for AFC, Ex. A at 24, Ex. B at 23-25. Petitioner also filed a supporting invoice on November 18, 2024. Pet’r’s Mot. for AFC, Ex. C. Petitioner’s counsel did not indicate that Petitioner incurred any additional expenses in pursuing this claim. Respondent responded to the motion on February 23, 2024, stating that Respondent “is satisfied that the statutory requirements for an award of attorneys’ fees and costs are met in this case.” Resp’t’s Resp. at 2, ECF No. 188. Respondent further stated, “[t]o the extent petitioner is requesting higher expert hourly rates than what has typically been awarded in the past, respondent submits that the Court should reserve the highest rates for the most qualified experts opining on the most complex medical issues . . . . ” and requesting that the Court “continue to make case-by-case determinations about a reasonable hourly rate, based upon the work performed, and any revised expert hourly rate ceiling should reflect the unique character of the Vaccine Program.” Id. at 3-4. Respondent “urges that the hourly rates paid to experts who appear on behalf of respondent ($375.00) be considered when determining an appropriate hourly rate.” Id. at 4. Petitioner filed a reply on February 27, 2024, asserting, in regard to expert costs, “the rate and amount sought by Petitioner is consistent to what has been awarded by this Court in the past for these experts” and requesting the fees and costs be awarded in full. Pet’r’s Reply at 1, ECF No. 189.

3 Petitioner’s former counsel, Mark L. Krueger, was previously awarded $39,717.06 in interim attorneys’ fees and costs. Bello v. Sec’y of Health & Human Servs., No. 13-349V, 2017 WL 785692 (Fed. Cl. Spec. Mstr. Jan. 24, 2017) 4 When added, the amount requested equals $66,137.95 not $66,137.97.

2 This matter is now ripe for consideration.

I. Reasonable Attorneys’ Fees and Costs

The Vaccine Act permits an award of “reasonable attorneys’ fees” and “other costs.” § 15(e)(1). If a petitioner succeeds on the merits of her or her claim, the award of attorneys' fees is automatic. Id.; see Sebelius v. Cloer, 133 S. Ct. 1886, 1891 (2013). However, a petitioner need not prevail on entitlement to receive a fee award as long as the petition was brought in “good faith” and there was a “reasonable basis” for the claim to proceed. § 15(e)(1). Here, although the petition was eventually dismissed, I am satisfied that good faith and reasonable basis have been met in the instant case. Respondent has also indicated he is satisfied that good faith and reasonable basis have been met. Accordingly, Petitioner is entitled to a final award of reasonable attorneys’ fees and costs.

The Federal Circuit has approved the lodestar approach to determine reasonable attorneys’ fees and costs under the Vaccine Act. Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1348 (Fed. Cir. 2008). This is a two-step process. Id. First, a court determines an “initial estimate . . . by ‘multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.’” Id. at 1347–48 (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)).

Free access — add to your briefcase to read the full text and ask questions with AI

Bello v. Secretary of Health and Human Services, (uscfc 2024).

Bello v. Secretary of Health and Human Services (Bello v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Blum v. Stenson
465 U.S. 886 (Supreme Court, 1984)
Avera v. Secretary of Health and Human Services
515 F.3d 1343 (Federal Circuit, 2008)
Sebelius v. Cloer
133 S. Ct. 1886 (Supreme Court, 2013)
Savin v. Secretary of Health & Human Services
85 Fed. Cl. 313 (Federal Claims, 2008)